RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.94B
AUM Growth
-$52.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$111M
2
+$29.3M
3
+$27.4M
4
HNGE
Hinge Health
HNGE
+$15.5M
5
TYRA icon
Tyra Biosciences
TYRA
+$14.9M

Top Sells

1
+$58.6M
2
+$46.8M
3
+$45.6M
4
URGN icon
UroGen Pharma
URGN
+$35.5M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$33.1M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma
ASND
$12.9B
$1.77B 29.9%
10,281,496
PCVX icon
2
Vaxcyte
PCVX
$5.99B
$389M 6.55%
11,965,991
-223,158
RYTM icon
3
Rhythm Pharmaceuticals
RYTM
$7.17B
$351M 5.92%
5,561,359
-523,053
JANX icon
4
Janux Therapeutics
JANX
$1.94B
$258M 4.35%
11,189,693
RNA icon
5
Avidity Biosciences
RNA
$10.8B
$206M 3.48%
7,266,031
+965,623
ACLX icon
6
Arcellx
ACLX
$4.14B
$200M 3.37%
3,036,527
ETNB
7
DELISTED
89bio
ETNB
$195M 3.29%
19,889,683
SPRY icon
8
ARS Pharmaceuticals
SPRY
$916M
$190M 3.19%
10,860,977
NAMS icon
9
NewAmsterdam Pharma
NAMS
$4.47B
$184M 3.09%
10,138,938
SION
10
Sionna Therapeutics
SION
$1.59B
$181M 3.05%
10,445,322
CDTX icon
11
Cidara Therapeutics
CDTX
$6.91B
$164M 2.76%
3,365,523
+2,272,727
EWTX icon
12
Edgewise Therapeutics
EWTX
$2.69B
$130M 2.19%
9,902,633
+993,542
LENZ
13
LENZ Therapeutics
LENZ
$944M
$122M 2.06%
4,178,823
WVE icon
14
Wave Life Sciences
WVE
$1.26B
$118M 1.99%
18,202,009
TYRA icon
15
Tyra Biosciences
TYRA
$1.13B
$117M 1.97%
12,198,625
+1,561,335
GHRS icon
16
GH Research
GHRS
$899M
$93.6M 1.58%
7,676,697
+732,049
DYN icon
17
Dyne Therapeutics
DYN
$2.99B
$92.5M 1.56%
9,714,392
GERN icon
18
Geron
GERN
$760M
$85.1M 1.43%
60,379,366
IRON icon
19
Disc Medicine
IRON
$3.51B
$83.5M 1.41%
1,577,106
MLYS icon
20
Mineralys Therapeutics
MLYS
$3.29B
$83.2M 1.4%
6,147,280
SEPN
21
Septerna Inc
SEPN
$1.28B
$73.9M 1.25%
6,995,858
FULC icon
22
Fulcrum Therapeutics
FULC
$549M
$70.4M 1.19%
10,229,099
BCAX
23
Bicara Therapeutics
BCAX
$978M
$64.6M 1.09%
6,955,993
VOR icon
24
Vor Biopharma
VOR
$168M
$64.2M 1.08%
1,982,302
TSHA icon
25
Taysha Gene Therapies
TSHA
$1.24B
$54.4M 0.92%
23,555,648
+12,683,145
1
2 3 4